Leptin, Leptin! Read, See and Hear All About It!
JDRF recently participated in a news conference led by Dallas Mayor Tom Leppert and Laura Leppert that showcased JDRF’s partnership with Amylin Pharmaceuticals in a research study investigating Metreleptin as a potential therapy to improve blood glucose control in type 1 diabetes.
This study is being based at UT-Southwestern Medical Center with Dr. Roger Unger, Dr. Abhimanyu Garg and Dr. Gregory Clark. Read more about this diabetes research. We wanted to share with you some of the great press and coverage we received from this news conference.
- Dallas Morning News: UT Southwestern Researchers Studying New Treatment for Type 1 Diabetes
- KERA Public Broadcasting for North Texas: Diabetics Could Benefit From Dallas Experiment
- Dallas Business Journal: UT Southwestern Launches Diabetes Study
- Dallas Observer: Mayor Tom, Prominent Doctors and the Great Cliff Harris All Come Together To Fight Diabetes
We were also featured on several News Stations!
NBC 5 Today 12/21/2010; CBS 11 News at 4pm 12/21/2010; NBC 5 First at Four 12/21/2010; Univision Conteo De Noticias at 5pm 12/21/2010; WFAA-TV News 8 at Five 12/21/2010; Fox 4 News at 5:30 12/21/2010; WFAA-TV News 8 at Six 12/21/2010; Fox 4 News at Nine 12/21/2010; TXCN Evening News 12/21/2010; NBC Five News 12/21/2010; Univision Conteo De Noticias at 10pm 12/21/2010; WFAA News 8 Daybreak 12/22/2010; Good Morning Texas 12/22/2010; Univision Noticias 23 at 10pm 12/25/2010
View the CBS 11 News at 4pm clip
View the Fox 4 News at Nine clip
View the Univision Noticias 23 clip
YOU’RE INVITED to hear Dr. Clark talk about the Metreleptin Study at our upcoming Diabetes Research Update & Board Meeting on Thursday, January 20, 2011. Read all the details and be sure to RSVP.
.
To learn more about the JDRF Dallas chapter, visit our JDRF Dallas website!
